People casually use the term “BOTOX” to describe all of these products, though BOTOX® is a registered trademark that one company owns. These substances target the nervous system, disrupting the nerve signaling processes that stimulate muscle contraction. In order for any muscle to contract, the nerves release a chemical messenger called acetylcholine at the junction where nerve endings meet muscle cells. Acetylcholine attaches to receptors on the muscle cells and causes the cells to contract, or shorten. BOTOX, Dysport® and JeuveauTM injections prevent the release of acetylcholine, which stops the muscle cells from contracting. Within the medical and cosmetic industries, these medications are used in small, carefully researched doses for therapeutic and aesthetic purposes. Therapeutic uses of these products includes: hyperhidrosis (excessive underarm sweating), and can also be used for sweaty palms and feet using a "microtoxing" technique, TMJ pain, and for chronic migraine treatment.
In 2002, The FDA approved BOTOX for cosmetic use to treat Glabellar lines (frown lines between the eyebrows), Crow’s feet (lines at the outer corner of the eye) and Forehead lines (horizontal lines across the forehead). However, trained Aesthetic Injectors commonly use Botox for “off-label” treatment areas. BOTOX was the first neurotoxin used for cosmetic purposes in the US, and is arguably still the most popular toxin used for cosmetic purposes.
Jeuveau is the new kid on the block in regards to neurotoxins and may also be referred to as "New-Tox"by some providers. In 2019, Jeuveau received FDA approval as the first aesthetic-only neurotoxin in the U.S. for temporary improvement in the appearance of moderate to severe glabellar lines. BOTOX and Jeuveau use the same ingredients, but the formulation differs. BOTOX is an Allergan product, whereas Jeuveau is an Evolus product (different companies). Jeuveau’s Hi-Pure technology takes added steps to remove dangerous proteins and to aid with absorption. This makes the product potentially safer. It also has been designed with "natural expression" similar to Dysport as part of the toxin's characteristics.
In 1991, Dysport was approved for use for certain muscle spasm disorders in Europe and Asia under the brand name Dysport and eventually made its way to the United States in 2009 when the FDA-approved Dysport to treat forehead wrinkles and frown lines, making it only the second drug to be approved by the agency as a wrinkle treatment. Dysport (formerly known as Reloxin) is made from the same active ingredient as BOTOX. Dysport relaxes wrinkles while still allowing "natural expression" in the treated areas. Patient's preferring a more natural look may prefer Dysport.
What you can expect from our injectable services
Before we recommend BOTOX or any injectable as part of your treatment plan, we complete a comprehensive skin evaluation and review your medical history. This helps us identify underlying health issues like allergies that can negatively affect your injectable treatment.
During your treatment, we follow a custom-made plan that we design specifically to meet your needs. This ensures you receive the right dosage of Botox or dermal fillers in the right location, so your results look and feel natural. We can also customize a plan for maintenance injections to help you retain your results in the long term.